This helps support independent research and keeps this resource free
Nutrition (Burbank, Los Angeles County, Calif)
oral formulation (Rybelsus) also available Lixisenatide (Lyxumia) once-daily injection NICE guidance for type 2 diabetes (NG28) recommends GLP-1 receptor agonists in specific circumstances: typically as a third-line option when other treatments haven't achieved adequate glycaemic control, particularly in people with a BMI 35 kg/m (adjusted for ethnicity), or for whom weight loss would benefit other obesity-related comorbidities, or for whom insulin would have significant occupational implications
GLP-1 RAs are not indicated for type 1 diabetes and should not be used during pregnancy or breastfeeding unless the benefits clearly outweigh potential risks
By delivering a concentrated dose directly into your bloodstream, these injections can rapidly elevate your Vitamin D status, leading to increased energy, improved mood, and a stronger immune system